Id |
Subject |
Object |
Predicate |
Lexical cue |
T275 |
0-37 |
Sentence |
denotes |
SARS-CoV-2 RBD and Its Receptor, ACE2 |
T276 |
38-185 |
Sentence |
denotes |
Since SARS-CoV-2 and SARS-CoV share the same host cell receptor, it was early questioned whether SARS-CoV-2 retains the same RBD motif of SARS-CoV. |
T277 |
186-262 |
Sentence |
denotes |
SARS-CoV RBD corresponds to residues 306–527 of S protein (Li et al., 2005). |
T278 |
263-402 |
Sentence |
denotes |
Sequence analysis shows that residues 319–541 of SARS-CoV-2 (S319–341) share 73.9% sequence identity with SARS-CoV RBD (Wang et al., 2020). |
T279 |
403-533 |
Sentence |
denotes |
Accordingly, Wang et al. (2020) clearly demonstrated that S319–341 corresponds to SARS-CoV-2 RBD by immunofluorescence microscopy. |
T280 |
534-737 |
Sentence |
denotes |
Indeed SARS-CoV-2 S1 and S319–341 positively colocalized with GFP-tagged ACE2 expressed on cell surface of HEK cells, whereas this interaction did not occur with membrane-expressed hDPP4 (MERS receptor). |
T281 |
738-867 |
Sentence |
denotes |
Additionally, soluble ACE2 inhibited the interaction between viral proteins and ACE2-expressing cells in a dose-dependent manner. |
T282 |
868-944 |
Sentence |
denotes |
The SARS-CoV-2 RBD sequence was further investigated by structural analysis. |
T283 |
945-1342 |
Sentence |
denotes |
X-ray crystallography showed that SARS-CoV-2 RBD folds into two structural domains (Figure 8): (1) the core subdomain with five antiparallel β-strands (β1, β2, β3, β4, β7), (2) the external subdomain, which inserts between β4 and β7, and it is characterized by the two small β5 and β6 strands [β1’ and β2’ in Wang et al. (2020)] connected by a disulfide bond (Lan et al., 2020; Wang et al., 2020). |
T284 |
1343-1610 |
Sentence |
denotes |
In keeping with their high sequence homology, the 3D structure of SARS-COV-2 and SARS-CoV RBD nearly superimpose (RMSD = 0.475 Å for 128 Cα atoms; Wang et al., 2020) with the exception of the β5/β6 loop, which actually entailed the larger primary sequence difference. |
T285 |
1611-1845 |
Sentence |
denotes |
FIGURE 8 Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2. (A) Cartoon representation. (B) Gaussian surface representation. hACE2 is in green, the core of SARS-CoV-2 RBD is in red, and the RBM is in blue. |
T286 |
1846-1918 |
Sentence |
denotes |
The β1-β7 typical motifs of RBD (Lan et al., 2020) are indicated in (A). |
T287 |
1919-2009 |
Sentence |
denotes |
The structures have been drawn from PDB 6MOJ (Lan et al., 2020) by Mol on the PDB website. |
T288 |
2010-2087 |
Sentence |
denotes |
Several researchers investigated the interaction of SARS-CoV-2 RBD with ACE2. |
T289 |
2088-2174 |
Sentence |
denotes |
Unfortunately, each group committed to slightly different sequences of SARS-CoV-2 RBD. |
T290 |
2175-2335 |
Sentence |
denotes |
To avoid confusion, we will always report the actual sequence with respect to the S protein when the RBD under study differs from the canonical 319–541 stretch. |
T291 |
2336-2450 |
Sentence |
denotes |
In vitro affinity studies revealed dissociation constants of the ACE2-RBD complex in the 1–100 nM range (Table 1). |
T292 |
2451-2599 |
Sentence |
denotes |
Non univocal data are attributable to the dissimilar sequences that were investigated and/or to the immobilization procedures (Shang et al., 2020b). |
T293 |
2600-2791 |
Sentence |
denotes |
In spite of this variability, SARS-CoV-2 RBD was always found to bind ACE2 4–10 fold stronger than SARS-CoV RBD (Lan et al., 2020; Shang et al., 2020b; Walls et al., 2020; Wang et al., 2020). |
T294 |
2792-3009 |
Sentence |
denotes |
The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020). |
T295 |
3010-3187 |
Sentence |
denotes |
Paradoxically, however, it has been shown that the ACE2 binding affinity for the entire SARS-CoV-2 S protein is lower than or comparable to that of SARS S (Shang et al., 2020a). |
T296 |
3188-3431 |
Sentence |
denotes |
This surprising result suggests that SARS-CoV-2 RBD, albeit more potent, is less efficiently exposed than SARS-CoV RBD by the dynamic transition between the “closed” and “open” states, probably in order to escape the immune system of the host. |
T297 |
3432-3758 |
Sentence |
denotes |
Thus, the non-identical S1 sequences of SARS-CoV-2 and SARS-CoV reflect the molecular evolution of SARS-CoV-2 toward: (1) much stronger affinity toward ACE2, (2) reduced antigenicity of the RBD region (which is one of the most antigenic segments in the S protein), (3) greater and less specific cleavability by host proteases. |
T298 |
3759-3876 |
Sentence |
denotes |
Taken together, these properties account for the sophisticated strategy exploited by SARS-CoV-2 to invade host cells. |
T299 |
3877-3970 |
Sentence |
denotes |
TABLE 1 Binding affinity between SARS-CoV-2 spike (S) protein and S subset regions and ACE2. |
T300 |
3971-4008 |
Sentence |
denotes |
Sequence KD (nM) Method References |
T301 |
4009-4048 |
Sentence |
denotes |
SARS-2 S 14.7 SPR Wrapp et al., 2020 |
T302 |
4049-4086 |
Sentence |
denotes |
SARS-2 S 11.2 SPR Lei et al., 2020 |
T303 |
4087-4136 |
Sentence |
denotes |
SARS-2 S20–685 (S1) 94.6 SPR Wang et al., 2020 |
T304 |
4137-4189 |
Sentence |
denotes |
SARS-2 S319–541 (RBD) 133.3 SPR Wang et al., 2020 |
T305 |
4190-4239 |
Sentence |
denotes |
SARS-2 S319–541 (RBD) 4.7 SPR Lan et al., 2020 |
T306 |
4240-4287 |
Sentence |
denotes |
SARS-2 S319–529 44.2 SPR Shang et al., 2020b |
T307 |
4288-4354 |
Sentence |
denotes |
SARS-2 S319–591 34.6 Biolayer interferometry Wrapp et al., 2020 |
T308 |
4355-4420 |
Sentence |
denotes |
SARS-2 S328–533 1.2 Biolayer interferometry Walls et al., 2020 |